BFS
COGT icon

Bare Financial Services’s Cogent Biosciences COGT Stock Holding History

Bare Financial Services’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.04K Sell
27
-13
-33% -$480 ﹤0.01% 1233
2025
Q4 		$1.42K Buy
+40
New +$1.12K ﹤0.01% 995

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Bare Financial Services's COGT Position: Q1 2026 in Review

Bare Financial Services reduced its Cogent Biosciences (COGT) stake by 33% in Q1 2026, selling an estimated $480 and leaving 27 shares worth $1.04K. The position accounts for ﹤0.01% of the portfolio, ranked #1233.

Bare Financial Services first reported a position in COGT in Q4 2025 and has held it in 2 quarters since. The position peaked at $1.42K in Q4 2025. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

  • Bare Financial Services held 27 shares of Cogent Biosciences worth $1.04K as of Q1 2026.
  • Bare Financial Services sold 13 Cogent Biosciences shares in Q1 2026, an estimated $480.
  • Cogent Biosciences made up ﹤0.01% of Bare Financial Services's portfolio in Q1 2026, its #1233 holding.
  • Bare Financial Services first reported a position in Cogent Biosciences in Q4 2025 and has held it in 2 quarters since.
  • Bare Financial Services's Cogent Biosciences position peaked at $1.42K in Q4 2025.
  • 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on Bare Financial Services's 13F filing for Q1 2026, filed 14 May 2026.